Literature DB >> 15650408

Isofurans: novel products of lipid peroxidation that define the occurrence of oxidant injury in settings of elevated oxygen tension.

Joshua P Fessel1, L Jackson Roberts.   

Abstract

We recently reported the discovery of isofurans, novel products of free radical-induced peroxidation of arachidonic acid that exhibit favored formation with increasing oxygen concentrations. In this review, the biochemistry of isofuran formation is compared with that of isoprostanes, with an emphasis on the mechanistic basis for the favored formation of isofurans at elevated oxygen tensions. In addition, the formation of isofurans in various disease states in vivo is also discussed. Parkinson's disease is presented as a disease model involving mitochondrial dysfunction, a situation in which quantification of isofurans can provide a uniquely sensitive indicator of oxidant injury. Measurement of isofurans has also provided unexpected insights into the earliest events in hyperoxic lung injury, an important clinical problem in which measurement of isofurans might prove to be uniquely valuable in the evaluation of approaches to limit this injury. These two settings are then used as models to suggest a variety of other pathological settings in which measurement of isofurans together with isoprostanes could provide a complete and robust picture of oxidative stress status in ongoing and future investigations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15650408     DOI: 10.1089/ars.2005.7.202

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  22 in total

1.  Oxidized Low-density Lipoprotein and the Incidence of Age-related Macular Degeneration.

Authors:  Ronald Klein; Kristine E Lee; Michael Y Tsai; Karen J Cruickshanks; Ronald E Gangnon; Barbara E K Klein
Journal:  Ophthalmology       Date:  2018-12-17       Impact factor: 12.079

2.  Effect of Coenzyme Q10 on Biomarkers of Oxidative Stress and Cardiac Function in Hemodialysis Patients: The CoQ10 Biomarker Trial.

Authors:  Matthew B Rivara; Catherine K Yeung; Cassianne Robinson-Cohen; Brian R Phillips; John Ruzinski; Denise Rock; Lori Linke; Danny D Shen; T Alp Ikizler; Jonathan Himmelfarb
Journal:  Am J Kidney Dis       Date:  2016-12-04       Impact factor: 8.860

3.  The short-term effects of antioxidant and zinc supplements on oxidative stress biomarker levels in plasma: a pilot investigation.

Authors:  Milam A Brantley; Melissa P Osborn; Barton J Sanders; Kasra A Rezaei; Pengcheng Lu; Chun Li; Ginger L Milne; Jiyang Cai; Paul Sternberg
Journal:  Am J Ophthalmol       Date:  2012-03-03       Impact factor: 5.258

4.  Plasma biomarkers of oxidative stress and genetic variants in age-related macular degeneration.

Authors:  Milam A Brantley; Melissa P Osborn; Barton J Sanders; Kasra A Rezaei; Pengcheng Lu; Chun Li; Ginger L Milne; Jiyang Cai; Paul Sternberg
Journal:  Am J Ophthalmol       Date:  2011-10-29       Impact factor: 5.258

5.  Hemoglobin attenuates the effects of inspired oxygen on plasma isofurans in humans during upper-limb surgery.

Authors:  Tomas B Corcoran; Anne E Barden; Emilie Mas; Sina Grape; Viktoria Koren; Michael Phillips; L Jackson Roberts; Trevor A Mori
Journal:  Free Radic Biol Med       Date:  2011-06-27       Impact factor: 7.376

6.  Plasma biomarkers of oxidant stress and development of organ failure in severe sepsis.

Authors:  Lorraine B Ware; Joshua P Fessel; Addison K May; L Jackson Roberts
Journal:  Shock       Date:  2011-07       Impact factor: 3.454

7.  Markers of inflammation, oxidative stress, and endothelial dysfunction and the 20-year cumulative incidence of early age-related macular degeneration: the Beaver Dam Eye Study.

Authors:  Ronald Klein; Chelsea E Myers; Karen J Cruickshanks; Ronald E Gangnon; Lorraine G Danforth; Theru A Sivakumaran; Sudha K Iyengar; Michael Y Tsai; Barbara E K Klein
Journal:  JAMA Ophthalmol       Date:  2014-04-01       Impact factor: 7.389

8.  The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia.

Authors:  Lorraine B Ware; Jason D Christie; Joshua M Diamond; Mary K Porteous; L Jackson Roberts; Nancy Wickersham; Melanie Rushefski; Steven M Kawut; Rupal J Shah; Edward Cantu; David J Lederer; Shampa Chatterjee; Vibha N Lama; Sangeeta Bhorade; Maria Crespo; John McDyer; Keith Wille; Jonathan Orens; Ann Weinacker; Selim Arcasoy; Pali D Shah; David S Wilkes; Chadi Hage; Scott M Palmer; Laurie Snyder; Carolyn S Calfee
Journal:  J Heart Lung Transplant       Date:  2016-01-07       Impact factor: 10.247

9.  Hyperoxia synergizes with mutant bone morphogenic protein receptor 2 to cause metabolic stress, oxidant injury, and pulmonary hypertension.

Authors:  Joshua P Fessel; Charles R Flynn; Linda J Robinson; Niki L Penner; Santhi Gladson; Christie J Kang; David H Wasserman; Anna R Hemnes; James D West
Journal:  Am J Respir Cell Mol Biol       Date:  2013-11       Impact factor: 6.914

10.  Role of mitochondria-derived reactive oxygen species in microvascular dysfunction in chronic kidney disease.

Authors:  Danielle L Kirkman; Bryce J Muth; Meghan G Ramick; Raymond R Townsend; David G Edwards
Journal:  Am J Physiol Renal Physiol       Date:  2017-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.